Omar Abudayyeh is Co-Founder of Helios Intelligence, a Y Combinator-backed company building an at-home blood test that reads more than 1,000 biomarkers to model a person's health.

Omar earned a B.S. from MIT in 2012 and a PhD in Feng Zhang's lab at the Broad Institute, where he co-led work on CRISPR enzymes including Cas12 and Cas13. He is now an Assistant Professor at Harvard Medical School and co-runs the Abudayyeh-Gootenberg lab.

Omar is the child of immigrants from Jordan and Kuwait and was a 2013 Paul and Daisy Soros Fellow. He was named to MIT Technology Review's Innovators Under 35 and the Forbes 30 Under 30 list.

Omar co-founded Sherlock Biosciences, Proof Diagnostics, Tome Biosciences and Terrain Biosciences, covering CRISPR diagnostics, gene editing therapeutics and AI mRNA design. Helios Intelligence's seed round is backed by Y Combinator and Formation.

His biotech ventures have collectively raised over $300 million, with multiple exits. At Helios, he is helping pursue the goal of simulating all of human health from a single drop of blood.